Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer
Study Type: Treatment
Phase: III
NCTID: NCT06274047
Principal Investigator:
Xinglei Shen
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients
Study Type: Supportive Care
Phase: III
NCTID: NCT05838716
Principal Investigator:
Elizabeth Wulff
A Phase III, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA IT PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection
Study Type: Diagnostic
Phase: III
NCTID: NCT06235151
Principal Investigator:
William Parker
The Phase III ?High Five Trial? Five Fraction Radiation For High-Risk Prostate Cancer
Study Type: Treatment
Phase: III
NCTID: NCT05946213
Principal Investigator:
Jay Shiao
The Role of Androgen Deprivation Therapy In CArdiovascular Disease ? A Longitudinal Prostate Cancer Study RADICAL PC1 and A RAndomizeD Intervention for CArdiovascular and Lifestyle Risk Factors in Prostate Cancer Patients RADICAL PC2
Study Type: Prevention
Phase: IV
NCTID: NCT03127631
Principal Investigator:
Charles Porter
Quantifying Optimal Relugolix Duration with Radiation in High Risk Prostate Cancer QURE-PC
Study Type: Treatment
Phase: II
NCTID: NCT06129851
Principal Investigator:
Xinglei Shen
AcTFirst: A phase III, open-label, multi-center, randomized study comparing AAA817+ARPI versus standard of care in adult participants with PSMA-positive metastatic castration resistant prostate cancer
Study Type: Treatment
Phase: III
NCTID: NCT06855277
Principal Investigator:
Xinglei Shen
Phase 2 randomized Total Eradication of metastatic lesions following definitive Radiation to the Prostate in de novo oligometaStatic prostate cancer TERPS trial
Study Type: Treatment
Phase: II
NCTID: NCT05223803
Principal Investigator:
Xinglei Shen
An Open-Label, Multicenter Phase 1/2 Study to Evaluate the Safety and Efficacy of AB-3028 in Patients with Castration Resistant Prostate Cancer CRPC
Study Type: Treatment
Phase: I/II
NCTID: NCT07285694
Principal Investigator:
Saqib Abbasi
An International, Prospective, Open-label, Multi-center, Randomized Phase III Study comparing lutetium 177Lu vipivotide tetraxetan AAA617 versus Observation to delay castration or disease recurrence in adult male patients with prostate-specific membrane antigen PSMA positive Oligometastatic Prostate Cancer OMPC
Study Type: Treatment
Phase: III
NCTID: NCT05939414
Principal Investigator:
Xinglei Shen